We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen, Novartis Partner on Alzheimer’s, Migraine Treatments
Amgen, Novartis Partner on Alzheimer’s, Migraine Treatments
Amgen and Novartis have launched a neuroscience drug collaboration to develop and commercialize new inhibitors to fight Alzheimer’s disease and treat migraines.